Evidence map›Paper›PMID 30823908›Full record

ArticleBMC cancer2019

Correction to: miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.

Pengfei Cao, Meili Zhang, Lujuan Wang, Buqing Sai, Jiuqi Tang, Zhaohui Luo, Cijun Shuai, Liyang Zhang, Zheng Li, Yanjin Wang and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Pengfei CaoKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Meili ZhangKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Lujuan WangKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Buqing SaiKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Jiuqi TangKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of EducationCancer Research Institute, Central South University, Changsha, 410078, Hunan, China.
Zhaohui LuoKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of EducationCancer Research Institute, Central South University, Changsha, 410078, Hunan, China.
Cijun ShuaiState Key Laboratory of High Performance Complex Manufacturing, Central South University, Changsha, 410083, Hunan, China.
Liyang ZhangPeople's Hospital of Dezhou, Dezhou, 253045, Shandong, China.
Zheng LiKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Yanjin WangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Guiyuan LiKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China.
Juanjuan XiangKey Laboratory of Carcinogenesis of Ministry of Health, Xiangya Hospital, Central South University, Changsha, 410078, Hunan, China. xiangjj@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aaaa.

Identifiers

PMID30823908
PMCPMC6396492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.